<DOC>
	<DOCNO>NCT00661206</DOCNO>
	<brief_summary>The purpose study determine whether 6 month duration clopidogrel therapy DES implantation inferior 12 month therapy .</brief_summary>
	<brief_title>Safety Efficacy Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting</brief_title>
	<detailed_description>Drug elution stent strut associate less smooth muscle cell proliferation delay stent strut re-endothelialization . Thus seem conceivable long duration dual antiplatelet therapy ( aspirin clopidogrel ) DES implantation need . However , study do investigate optimal antiplatelet therapy duration DES implantation . Therefore , objective randomize , double-blind , placebo-controlled ISAR-SAFE study evaluate safety efficacy 6 month versus 12 month duration clopidogrel therapy DES implantation . Patients clopidogrel therapy least 6 month DES implantation , require reintervention randomize additional 6 month period clopidogrel placebo . The patient followed-up 9 month randomization .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>Patients clopidogrel therapy 6 month ( 1/+2 month ) DES implantation Informed , write consent patient Age â‰¤18 year Clinically symptom , proof ischemia and/or presence angiographic lesion require revascularization Previous stent thrombosis DES leave main coronary artery STelevation nonSTelevation myocardial infarction last 6 month Malignancies comorbid condition life expectancy le one year may result protocol noncompliance Planned major surgery within next 6 month need discontinue antiplatelet therapy Active bleeding ; bleed diathesis ; history intracranial bleed Oral anticoagulation therapy coumadin derivative Known allergy intolerance study medication : aspirin clopidogrel Pregnancy ( present , suspected plan ) positive pregnancy test ( In woman childbearing potential negative pregnancy test mandatory ) Patient 's inability fully comply study protocol Prior enrollment clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Clopidogrel</keyword>
	<keyword>Drug-eluting stent</keyword>
</DOC>